Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Durvalumab and tremelimumab
Study Title: A study to learn about durvalumab and tremelimumab
for participants with advanced solid tumors who are
getting chemotherapy
Thank you!
Thank you for taking part in this clinical study for the study drugs durvalumab and
tremelimumab.
AstraZeneca AB sponsored this study and believes it is important to share the results. An
independent non-profit organization called CISCRP helped prepare this summary of the
study results for you.
If you participated in this study and have questions about the results, please speak with
the study doctor or staff at your study site.
Who took part in the study?
The researchers asked for the help of people with advanced solid tumors. The
participants in this study were 31 to 81 years old when they joined.
The study included 32 participants in Japan and South Korea.
1